Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Altered endothelial function as a cardiovascular risk index in patients with metabolic syndrome
2005-001024-36Phase 2Completed
- Sponsor
- Centro Cardiologico Monzino
- Start
- Mar 2007
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of arginine in cardiometabolic risk (CMR) and endothelial dysfunction, sponsored by Centro Cardiologico Monzino. Started Mar 2007; status: completed.
02
Drugs
arginine
03
Conditions
cardiometabolic risk (CMR)endothelial dysfunction
Beyond the preview
Go deeper on 2005-001024-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001024-36.